New Antifungal Drugs, New Approaches and Vaccines Antifungal name Choose antifungalAlbaconazoleAlpha-asaroneAmorolfineAR-12ASP2397 (VL-2397)ASP9726AuranofinAureobasidin ABHBMBiafungin (CD101)CD101Ceragenin CSA-131CorifunginE1210Encochleated AmB (MAT023)EV-086F901318 (olorofim)FG 3622FK506 (tacrolimus) and L-685,818FR290581General articlesGM 237354GriseofulvinHaemofunginIbomycinIbrexafungerp (SCY-078, MK-3118)Icofungipen (PLD-118)Ilicicolin HKOSN-2079 (polyketide)L365L743L884Macrocyclic amidinoureasManumycin AMAT2203MGCD290MycograbMyriocinNebulised AmpBNikkomycin ZNovamycin (NP339)Novexatin (NP213)P11-6PC945PolyoxinPradimicins (inc. BMS-181184)R-135853SampangineSM21SPK-843StatinsT-2307TacrolimusTavaborole (AN2690)TipifarnibTurbinmicinVaccinesVT-1129VT-1161VT-1598YO-001A Showing 10 posts of 219 posts found. Title Trail phase Date A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Non-fasting Conditions Phase 1 17 March 2009 A Relative Bioavailability Study of Griseofulvin 125 mg/5 mL Suspension Under Fasting Conditions Phase 1 17 March 2009 Safety and PK of Nikkomycin Z for Coccidioides Pneumonia Treatment Phase 2 31 January 2008 Comparison of Nikkomycin Z Bioavailability Under Fed and Fasting Conditions Phase 1 16 July 2012 Safety and PK of Nikkomycin Z in Healthy Subjects Phase 1 2 February 2009 Oral SCY-078 vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis Phase 2 12 September 2014 Efficacy, Safety and Pharmacokinetics of SPK-843 in the Treatment of Pulmonary Mycosis Phase 3 17 May 2010 Resin vs. Amorolfine vs. Terbinafine Treatment in Onychomycosis Phase 4 1 October 2015 Viamet Gets Orphan Drug Designation for VT-1129 16 September 2014 Viamet to Present at ICAAC/ICC 2015 10 September 2015 Previous1...1213141516171819202122Next
